Global Large Molecule Bioanalytical Testing Service Market by Phases (Preclinical, With Antibody, Without Antibody (ELISA Based Assay), and Clinical), Types (Pharmacokinetics, ADA, and Others), Test Types (ADME, PK, PD, Bioavailability, Bioequivalence, and Other Tests), Therapeutic Areas (Oncology, Infectious Diseases, Cardiology, Neurology, and Others), End-users (SMEs [CROs & CMOs, Sponsor Organizations, and Others] and Large Firms [CROs & CMOs, Sponsor Organizations, and Others]), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2020-2027
The global large molecule bioanalytical testing service market is anticipated to expand at substantial CAGR during forecast period, between 2020 and 2027. Large molecule bioanalysis operates in the field of analytical chemistry. These large drug molecules are effective in treating a range of indications of chronic illness. The growth of the biopharmaceutical R&D pipeline has boosted the demand for large molecules bioanalytical testing services; therefore, many biopharmaceutical companies are introducing large-scale outsourcing services. Bioanalytical research of big molecules has always been a challenge for the biopharmaceutical industry. Various specialized methods are HRMS, scale exclusion affinity chromatography, ligand binding assays (LBA) and Maldi-TOF-MS. Bioanalytical studies for large molecules can easily be conducted using these advanced techniques.
Market Trends, Drivers, Restraints, and Opportunities:
- Technological advancements in bioanalytical research for the large molecule fuels market growth.
- Increase in emphasis on analytical testing, rise in research & development costs in the pharmaceutical and biopharmaceutical industries, and growth in the demand for analytical test outsourcing fuel market growth.
- Compliance issues while outsourcing large molecule bioanalytical testing services are expected to hamper the market.
Scope of the report:
The report on large molecule bioanalytical testing service market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.|
Attributes |
Details |
|
Base Year |
2019 |
|
Historic Data |
2017 & 2018 |
|
Forecast Period |
2020–2027 |
|
Regional Scope |
Asia Pacific, North America, Europe, Latin America, and Middle East & Africa |
|
Report Coverage |
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast |
Large Molecule Bioanalytical Testing Service Market Segment Insights:
The clinical segment is projected to hold significant market share
In the terms of phases, the large molecule bioanalytical testing service market has been segmented into preclinical, with antibody, without antibody (ELISA-based assay), and clinical. The clinical segment is projected to grow at a significant pace during the forecast period due to the growing prevalence of chronic diseases in developing countries and rising need for clinical trials.
Antidrug antibodies (ADA) segment held substantial market share in 2019
Based on types, the market is fragmented into pharmacokinetics, ADA, and others. The antidrug antibodies (ADA) segment holds significant market share is projected to expand at rapid rate during the forecast period. ADA assays promote large molecular drug production.
Bioavailability segment is expected to grow during the forecast period
On the basis of test types, the large molecule bioanalytical testing service market has been segregated into ADME, PK, PD, bioavailability, bioequivalence, and other tests. The bioavailability segment is expected to hold significant market share during the forecast period. The bioavailability of a pharmaceutical medicine partly depends on the characteristics of a dosage form. It plays a key role in pharmacokinetics, as it is taken non-intravenous dose calculations.
Surge in prevalence of cancer fuels the oncology segment
In terms of therapeutic areas, the market is classified as oncology, infectious diseases, cardiology, neurology, and others. The oncology segment holds a significant share of the market due to high prevalence of cancer across the globe. The cardiology segment is projected to expand at substantial CAGR during the forecast period.
Small and Medium Enterprises (SMEs) segment holds significant market share
Based on end-users, the large molecule bioanalytical testing service market is bifurcated into SME and large firm. Both segments are further divided into CROs & CMOs, sponsor organizations, and others. The development of biopharmaceutical inventions in the US, for example, due to increase in the demand for SMEs for products, processes, and services.
North America dominates the global market
In terms of regions, the global large molecule bioanalytical testing service market is split into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounts for a considerable share of the large molecule bioanalytical testing service market. The US has numerous manufacturing facilities for extremely effective, complex, and high-end medications. The market is expected to develop significantly in the US during the forecast period due to the rapid increase in biologic production to meet the growing demand for efficient medical care in the country, strong R&D, and promotion of new therapies.
Competitive Landscape:
Key players in the large molecule bioanalytical testing service market include Charles River Laboratory International, Covance, Inc., ICON Plc, Intertek Group plc, IQVIA, Pace Analytical Services LLC, PPD, INC., SGS SA, Syneos Health, and Toxikon. Mergers & acquisitions, collaborations, agreements, and partnerships are some growth strategies adopted by these players to strengthen their geographical presence.
Segments Covered in the Report
By Phases
- Preclinical
- With Antibody
- Without Antibody (ELISA Based Assay)
- Clinical
By Types
- Pharmacokinetics
- ADA
- Others
By Test Types
- ADME
- PK
- PD
- Bioavailability
- Bioequivalence
- Other Tests
By Therapeutic Areas
- Oncology
- Infectious Diseases
- Cardiology
- Neurology
- Others
By End-users
- SMEs
- CROs & CMOs
- Sponsor Organizations
- Others (Academic institute, etc.)
- Large Firms
- CROs & CMOs
- Sponsor Organizations
- Others (Academic institute, etc.)
By Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
2. Assumptions and Acronyms Used
3. Research Methodology
4. Large Molecule Bioanalytical Testing Service Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Large Molecule Bioanalytical Testing Service Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Large Molecule Bioanalytical Testing Service Market - Supply Chain
4.5. Global Large Molecule Bioanalytical Testing Service Market Forecast
4.5.1. Large Molecule Bioanalytical Testing Service Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Large Molecule Bioanalytical Testing Service Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Large Molecule Bioanalytical Testing Service Market Absolute $ Opportunity
5. Global Large Molecule Bioanalytical Testing Service Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
5.3.1. Pharmacokinetics
5.3.2. ADA
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Large Molecule Bioanalytical Testing Service Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
6.3.1. SMEs
6.3.2. CROs & CMOs
6.3.3. Sponsor Organizations
6.3.4. Others (Academic institute, etc.)
6.3.5. Large Firms
6.3.6. CROs & CMOs
6.3.7. Sponsor Organizations
6.3.8. Others (Academic institute, etc.)
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Large Molecule Bioanalytical Testing Service Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
8. North America Large Molecule Bioanalytical Testing Service Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
8.4.1. Pharmacokinetics
8.4.2. ADA
8.4.3. Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
8.7.1. SMEs
8.7.2. CROs & CMOs
8.7.3. Sponsor Organizations
8.7.4. Others (Academic institute, etc.)
8.7.5. Large Firms
8.7.6. CROs & CMOs
8.7.7. Sponsor Organizations
8.7.8. Others (Academic institute, etc.)
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
9. Latin America Large Molecule Bioanalytical Testing Service Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
9.4.1. Pharmacokinetics
9.4.2. ADA
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
9.7.1. SMEs
9.7.2. CROs & CMOs
9.7.3. Sponsor Organizations
9.7.4. Others (Academic institute, etc.)
9.7.5. Large Firms
9.7.6. CROs & CMOs
9.7.7. Sponsor Organizations
9.7.8. Others (Academic institute, etc.)
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
10. Europe Large Molecule Bioanalytical Testing Service Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
10.4.1. Pharmacokinetics
10.4.2. ADA
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
10.7.1. SMEs
10.7.2. CROs & CMOs
10.7.3. Sponsor Organizations
10.7.4. Others (Academic institute, etc.)
10.7.5. Large Firms
10.7.6. CROs & CMOs
10.7.7. Sponsor Organizations
10.7.8. Others (Academic institute, etc.)
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
11. Asia Pacific Large Molecule Bioanalytical Testing Service Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
11.4.1. Pharmacokinetics
11.4.2. ADA
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
11.7.1. SMEs
11.7.2. CROs & CMOs
11.7.3. Sponsor Organizations
11.7.4. Others (Academic institute, etc.)
11.7.5. Large Firms
11.7.6. CROs & CMOs
11.7.7. Sponsor Organizations
11.7.8. Others (Academic institute, etc.)
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
12. Middle East & Africa Large Molecule Bioanalytical Testing Service Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
12.4.1. Pharmacokinetics
12.4.2. ADA
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
12.7.1. SMEs
12.7.2. CROs & CMOs
12.7.3. Sponsor Organizations
12.7.4. Others (Academic institute, etc.)
12.7.5. Large Firms
12.7.6. CROs & CMOs
12.7.7. Sponsor Organizations
12.7.8. Others (Academic institute, etc.)
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Large Molecule Bioanalytical Testing Service Market: Market Share Analysis
13.2. Large Molecule Bioanalytical Testing Service Distributors and Customers
13.3. Large Molecule Bioanalytical Testing Service Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Charles River Laboratory International
13.4.2. Covance Inc.
13.4.3. ICON Plc
13.4.4. Intertek Group plc
13.4.5. IQVIA
13.4.6. Pace Analytical Services LLC
13.4.7. PPD INC.
13.4.8. SGS SA
13.4.9. Syneos Health
13.4.10. Toxikon
Segments Covered in the Report
By Phases
- Preclinical
- With Antibody
- Without Antibody (ELISA Based Assay)
- Clinical
By Types
- Pharmacokinetics
- ADA
- Others
By Test Types
- ADME
- PK
- PD
- Bioavailability
- Bioequivalence
- Other Tests
By Therapeutic Areas
- Oncology
- Infectious Diseases
- Cardiology
- Neurology
- Others
By End-users
- SMEs
- CROs & CMOs
- Sponsor Organizations
- Others (Academic institute, etc.)
- Large Firms
- CROs & CMOs
- Sponsor Organizations
- Others (Academic institute, etc.)
By Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
Key Players in the market
- Charles River Laboratory International
- Covance Inc.
- ICON Plc
- Intertek Group plc
- IQVIA
- Pace Analytical Services LLC
- PPD INC.
- SGS SA
- Syneos Health
- Toxikon
Our Clients
Related Reports
Some other reports from this category!
